What's Happening?
The Every Company, known for its animal-free egg white products, is significantly increasing its manufacturing capacity in response to a surge in demand. The company announced that orders for its flagship product, OvoPro, have grown by 550% in the first
four months of 2026 compared to the entire previous year. This growth is attributed to the product's nationwide availability in major retailers like Walmart and Target, as well as increased demand across e-commerce and foodservice channels. To meet this demand, The Every Company is partnering with Huvepharma to expand production at a facility in Bulgaria, which boasts over 9 million liters of fermentation capacity. The company has also launched its Animal-Free Egg White Protein Powder for consumers, making it available for purchase on platforms like Amazon and Healthier Comforts.
Why It's Important?
The expansion of The Every Company's production capabilities highlights the growing consumer interest in sustainable and ethical food products. As the demand for plant-based and animal-free alternatives increases, companies like The Every Company are positioned to capitalize on this trend. The ability to produce egg proteins without the supply chain challenges associated with traditional egg production offers a significant advantage. This development not only supports the company's growth but also contributes to the broader movement towards more sustainable food systems. The increased availability of animal-free products in mainstream retail channels indicates a shift in consumer preferences and a potential reduction in the environmental impact of food production.
What's Next?
The Every Company's continued expansion and investment in production capacity suggest that the company is preparing for sustained growth in the animal-free protein market. As consumer awareness and demand for sustainable products increase, the company may explore further partnerships and innovations to enhance its product offerings. Additionally, the success of the OvoPro product could encourage other companies to invest in similar technologies, potentially leading to a more diverse range of animal-free products in the market. The company's recent Series D financing round, which raised $55 million, will likely support these efforts and enable further market penetration.
